Fragility Fracture
21
10
11
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
4.8%
1 terminated out of 21 trials
50.0%
-36.5% vs benchmark
19%
4 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (21)
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
Essential Amino Acid Supplementation for Femoral Fragility Fractures
Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures
Image-guided Computational and Experimental Analyses of Fractured Patient's Bone (GAP)
MyNOURISH: Hydrolysed Collagen Supplementation in Older Adults With Fragility Fractures
Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
PRevEnting FracturEs in REnal Disease - 1
Sacral Fracture Fusion/Fixation for Rapid Rehabilitation
Impact of a Clinical Pathway for Pelvic Fragility Fractures
PRevention of OsTEoporotiC FracTure 2 Pilot Study
Motivational Interventions and Physical Exercise in Patients With Fragility Fracture
Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability
The Role of Augmented Fixation Techniques in Fragility Fracture Pelvis (FFP)
Role of Strontium Ranelate in Proximal Femur Fragility Fractures.
Iron Supplementation for Geriatric Hip Fractures
Hip Fracture Prevention Follow-up of Elderly Women in Primary Health Care
Femoral frACturEs and COVID-19.